Trends in disparities in receipt of adjuvant therapy for elderly stage III colon cancer patients: the role of the medical oncologist evaluation., A J. Davidoff, T Rapp, E Onukwugha, I H. Zuckerman, N Hanna, Naushira Pandya, C D. Mullins
Naushira Pandya

Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients., C D. Mullins, F Y. Hsiao, E Onukwugha, Naushira Pandya, N Hanna
Faculty Articles

Comparative effectiveness of different chemotherapeutic regimens on survival of people aged 66 and older with stage III colon cancer: a "real world" analysis using Surveillance, Epidemiology, and End Results-Medicare data., F Y. Hsiao, C D. Mullins, E Onukwugha, Naushira Pandya, N Hanna
Faculty Articles

Chemotherapy treatment and survival in older women with estrogen receptor-negative metastatic breast cancer: a population-based analysis., M Schneider, I H. Zuckerman, E Onukwugha, Naushira Pandya, B Seal, J Gardner, C D. Mullins
Faculty Articles

Trends in disparities in receipt of adjuvant therapy for elderly stage III colon cancer patients: the role of the medical oncologist evaluation., A J. Davidoff, T Rapp, E Onukwugha, I H. Zuckerman, N Hanna, Naushira Pandya, C D. Mullins
Faculty Articles